MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ctcp.2023.101800

Медицинская библиотека · Complementary therapies in clinical practice · 2023

Placebo response in sham-acupuncture-controlled trials for migraine: A systematic review and meta-analysis.

Sun Chengyi, Xiong Zhiyi, Sun Chongyang, Liu Tinglan, Liu Xiaoyu, Zhang Qinhong, Liu Baoyan, Yan Shiyan, Liu Cunzhi

МетаанализСистематический обзорСтатьяПеревод пока не подготовлен

Аннотация

AIM: To understand the placebo response of acupuncture and its effect on migraine and optimize the design of future acupuncture clinical trials on migraine treatment.

METHODS

Randomized controlled trials with sham acupuncture as a control in migraine treatment were searched in four English databases from inception to September 1, 2022. The primary outcome was placebo response rate. Secondary outcomes were migraine symptoms, emotional condition, and quality of life. Factors associated with placebo response were also explored. Results were combined using risk difference (RD) or standardized mean difference (SMD) and 95% confidence interval (CI) with a random effects model.

RESULTS

The final analysis included 21 studies involving 1177 patients. The pooled response rate of sham acupuncture was 0.34 (RD, 95% CI 0.23-0.45, I2 89.8%). The results (SMD [95% CI]) showed significant improvements in migraine symptoms (pain intensity -0.56 [-0.73 to -0.38], and episode conditions -0.55 [-0.75 to -0.35]); emotional condition (anxiety scale -0.49 [-0.90 to -0.08] and depression scale -0.21 [-0.40 to -0.03]); and quality of life on the Migraine-Specific Quality-of-Life Questionnaire (restrictive 0.78 [0.61-0.95]; preventive 0.52 [0.35-0.68]; and emotional 0.45 [0.28-0.62]) and on the Medical Outcomes Study Short-Form (physical 0.48 [0.34-0.62] and mental 0.21 [0.02-0.41]). Only acupuncture treatment frequency had a significant impact on the placebo response rate (RD 0.49 vs. 0.14; p = 0.00).

CONCLUSIONS

The effect sizes for placebo response of sham acupuncture varied across migraine treatment trials. Further studies should routinely consider adjusting for a more complete set of treatment factors.

Для цитирования: Sun Chengyi, Xiong Zhiyi, Sun Chongyang, Liu Tinglan, Liu Xiaoyu, Zhang Qinhong, Liu Baoyan, Yan Shiyan, Liu Cunzhi. Placebo response in sham-acupuncture-controlled trials for migraine: A systematic review and meta-analysis.. Complementary therapies in clinical practice. 2023. DOI: 10.1016/j.ctcp.2023.101800.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.